Epidemiology of idiopathic cardiomyopathies in children and adolescents: A nationwide study in Finland

American Journal of Epidemiology

Volumn 146, Issue 5, 1997, Pages 385-393

  Arola, Anita ^a   Jokinen, Eero ^a   Ruuskanen, Olli ^a   Saraste, Markku ^a   Pesonen, Erkki ^b   Kuusela, Anna Leena ^c   Tikanoja, Tero ^d   Paavilainen, Terho ^e   Simell, Olli ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Cardiomyopathy, congestive; Cardiomyopathy, hypertrophic; Cardiomyopathy, restrictive; Child; Myocardial diseases

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CARDIOMYOPATHY; CHILD; CHILDHOOD DISEASE; FEMALE; FINLAND; HEART DILATATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 0030813394     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009291     Document Type: Article

References (47)

1. Kasper EK, Agema WR, Hutchins GM, et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994;23:586-90.
2. Ino T, Benson LN, Freedom RM, et al. Natural history and prognostic risk factors in endocardial fibroelastosis. Am J Cardiol 1988;62:431-4.
3. Maron BJ, Spirito P, Wesley Y, et al. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986;315: 610-14.
4. Ferencz C, Neill CA. Cardiomyopathy in infancy: observations in an epidemiologic study. Pediatr Cardiol 1992;13: 65-71.
5. Maron BJ, Tajik AJ, Ruttenberg HD, et al. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 1982;65:7-17.
6. Taliercio CP, Seward JB. Driscoll DJ, et al. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 1985;6:1126-31.
7. Friedman RA, Moak JP, Garson A Jr. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991;18:152-6.
8. Lewis AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 1992;123:1589-93.
9. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994;90:1310-18.
10. Bagger JP, Baandrup U, Rasmussen K, et al. Cardiomyopathy in western Denmark. Br Heart J 1984;52:327-31.
11. Codd MB, Sugrue DD. Gersh BJ, et al. Epidemiology of idiopathic dilated and hypertrophie cardiomyopathy: a population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989;80:564-72.
12. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Eighth Revision. Vol 2. Geneva, Switzerland: World Health Organization, 1967.
13. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Vol 1. Geneva, Switzerland: World Health Organization, 1977.
14. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
15. Lurie PR. Endocardial fibroelastosis is not a disease. (Editorial). Am J Cardiol 1988;62:468-70.
16. Roge CL, Silverman NH, Hart PA, et al. Cardiac structure growth pattern determined by echocardiography. Circulation 1978;57:285-90.
17. Seward JB. Restrictive cardiomyopathy: reassessment of definitions and diagnosis. Curr Opin Cardiol 1988;3:391-5.
18. Keren A, Popp RL. Assignment of patients into the classification of cardiomyopathies. Circulation 1992;86:1622-33.
19. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994;71:215-18.
20. Kirkwood BR, ed. Essentials of medical statistics. Oxford, England: Blackwell Scientific Publications, 1988.
21. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987; 18:619-24.
22. Suomalainen A, Paetau A, Leinonen H, et al. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992;340:1319-20.
23. Greenwood RD, Nadas AS, Fyler DC. The clinical course of primary myocardial disease in infants and children. Am Heart J 1976;92:549-60.
24. Gillum RF. Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J 1986;111:752-5.
25. Coughlin SS, Comstock GW, Baughman KL. Descriptive epidemiology of idiopathic dilated cardiomyopathy in Washington County, Maryland, 1975-1991. J Clin Epidemiol 1993; 46:1003-8.
26. DiMauro S, Nicholson JF, Hays AP, et al. Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol 1983;14:226-34.
27. Marin-Garcia J, Baskin LS. Human cytochrome c oxidase during cardiac growth and development. Pediatr Cardiol 1989; 10:212-15.
28. Rudolph AM. The changes in the circulation after birth: their importance in congenital heart disease. Circulation 1970;41: 343-59.
29. Webber SA, Boyle GJ, Pickering RM, et al. Role of right ventricular endomyocardial biopsy in infants and children with suspected or possible myocarditis. Br Heart J 1994;72: 360-3.
30. Chow LH, Radio SJ, Sears TD, et al. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989;14:915-20.
31. Mason JW, O'Connell JB, Herskowitz A, et al. The Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333:269-75.
32. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985;312:885-90.
33. Bowles NE, Rose ML, Taylor P, et al. End-stage dilated cardiomyopathy: persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 1989;80:1128-36.
34. Jin O, Sole MJ, Butany JW, et al. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990;82:8-16.
35. Kandolf R, Canu A, Klingel K, et al. Molecular studies on enteroviral heart disease. In: Brinton MA, Heinz FX, eds. New aspects of positive-strand RNA viruses. Washington, DC: American Society of Microbiology, 1990:340-8.
36. Anderson JL, Carlquist JF, Hammond EH. Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet 1982;2:1124-7.
37. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989;64:97-103.
38. Ansari AA, Wang Y-C, Danner DJ, et al. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol 1991;139:337-54.
39. Carlquist JF, Menlove RL, Murray MB, et al. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy: validation study and meta-analysis of published HLA association studies. Circulation 1991;83:515-22.
40. Caforio AL, Grazzini M, Mann JM, et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85: 1734-42.
41. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 1995;92:785-9.
42. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
43. Thierfelder L, Watkins H, MacRae C, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-12.
44. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995; 11:434-7.
45. Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995;11: 438-40.
46. Marian AJ, Yu Q-T, Workman R, et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-6.
47. Sapienza C. Genome imprinting and dominance modification. Ann N Y Acad Sci 1989;564:24-38.